Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
10/2005
10/27/2005WO2005007825A3 Modulation of aminopeptidase n expression
10/27/2005WO2004101740A3 Clotting factor-fc chimeric proteins to treat hemophilia
10/27/2005WO2004094598A3 Methods of use for novel human polypeptides encoded by polynucleotides
10/27/2005WO2004078940A8 USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF eIF-5A1
10/27/2005WO2004076629A3 METHODS AND CONSTRUCTS FOR EVALUATION OF RNAi TARGETS AND EFFECTOR MOLECULES
10/27/2005WO2003023008A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/27/2005US20050239701 Transient and/or permanent modification of sexual behavior and/or fertility using recombinant chimeric GnRH
10/27/2005US20050239700 Treatment of cancer using antibodies to LRRC15
10/27/2005US20050239102 Libraries of short nucleotide oligomers to bind the tertiary or globular structure of nucleic acids; kit identifies non-canonical binding oligomers; binding forces independent of Watson-Crick, Hoogstein base-pairing rules; Hepatitis C virus, Human Immnuodeficiency virus, Herpes virus
10/27/2005US20050239101 Quantitative multiplex methylation-specific PCR
10/27/2005US20050239087 Multiply-primed amplification of nucleic acid sequences
10/26/2005EP1589096A1 Method for producing L-amino acid
10/26/2005EP1587957A2 Gene expression markers for breast cancer prognosis
10/26/2005EP1587913A1 New strains of bifidobacterium having the ability to produce glutamine
10/26/2005EP1587912A2 Methods of identifying and designing cell surface receptor inhibitors
10/26/2005EP1587869A2 Membrane active polymers
10/26/2005EP1587550A2 Methods and compositions for administering therapeutic and diagnostic agents
10/25/2005CA2039165C Plants with modified flowers
10/20/2005WO2005049800A3 Methods for screening for agents capable of modulating t lymphocyte function in response to a herpes simplex virus-infected cell
10/20/2005WO2005010142A8 Plant centromere compositions
10/20/2005WO2005005603A3 Method for inducing an immune response to cancer antigen
10/20/2005WO2004090103A3 Identification of novel nogo-receptors and methods related thereto
10/20/2005WO2004007684A3 Synthetic tag genes
10/20/2005US20050235384 Compositions and methods for detecting a sequence mutation in the cinnamyl alcohol dehydrogenase gene associated with altered lignification in loblolly pine
10/20/2005US20050234007 RNA interference mediating small RNA molecules
10/20/2005US20050234006 RNA interference mediating small RNA molecules
10/20/2005US20050233429 vector and host cell comprising nucleic acid of invention; nucleic acid sequence encoding cyclcooxygenase-1 variant
10/20/2005US20050233411 Compositions and methods for cleaving IAP
10/20/2005US20050233347 Can be used for the treatment of diabetes or for delaying the onset of diabetes
10/19/2005EP1585827A2 Modulation of protein functionalities
10/19/2005EP0846173B1 Use of an anti-interleukin-9 antibody for the preparation of a medicament for the treatment of asthma
10/13/2005WO2005056769A3 Orally-administered live bacterial vaccines for plague
10/13/2005WO2005035715A3 Flanking dna sequences that control expression in the human genome
10/13/2005WO2005033288A3 Hedgehog pathway antagonists
10/13/2005WO2005021717A3 Oligonucleotide sequestering agents and methods of use
10/13/2005WO2005014788A3 Tssk4: a human testis specific serine/threonine kinase
10/13/2005WO2005001055A3 Stabilized immunomodulatory oligonucleotides
10/13/2005WO2004104176A3 Method for the identification of inhibitors of ornithine carbamoyltransferase, ketol-acid reductoisomerase, and fungal pathogenicity-conferring gene as antibiotics
10/13/2005WO2004092327A3 Method of generating size standard nucleic acids
10/13/2005WO2004081173A3 Nucleotide sequences regulating gene expression and constructs and methods utilizing same
10/13/2005WO2004072253A3 Human excitatory amino acid transporter-2 gene promoter and uses thereof
10/13/2005WO2003078570A8 Multiple controls for molecular genetic analyses
10/13/2005US20050229263 Transgenesis by sperm-mediated gene transfer
10/13/2005US20050227323 polynucleotide having nucleic acid sequences, encoding and expressing calcium-independent phospholipase A2 epsilon (iPLA2 epsilon ); for catalysis and hydrolysis of lipids in living cell biosystem; iPLA2 epsilon as a pharmacological target in drug screening anti-obesity drugs
10/13/2005US20050227318 Site-specific incorporation of redox active amino acids into proteins
10/13/2005US20050227238 Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74
10/13/2005US20050227235 Methods for high fidelity production of long nucleic acid molecules with error control
10/13/2005US20050227229 Multiple controls for molecular genetic analyses
10/13/2005US20050226904 Fibrous composite for tissue engineering
10/12/2005EP1584683A1 Human orphan g protein-coupled receptors
10/12/2005EP1137768B1 Human hybrid host cell for mammalian gene expression
10/11/2005CA2128589C Selection marker gene free recombinant strains: a method for obtaining them and the use of these strains
10/06/2005WO2005093041A1 Mutated xylose reductase in xylose-fermentation by s. cerevisiae
10/06/2005WO2005091733A2 Traits in recombinant xylose-growing saccharomyces cerevisiae strains using genome-wide transcription analysis
10/06/2005WO2005056751A3 Apparatus and method for concentrating stem cell
10/06/2005WO2005019434A3 Serine protease inhibitors for treatment of bacterial infections
10/06/2005WO2004094609A3 Methods for characterizing signaling pathways and compounds that interact therewith
10/06/2005WO2004094603A3 Transgenic mouse with simplified dh locus
10/06/2005WO2004065570A3 Methods of metallizing nucleic acid molecules and methods of attaching nucleic acid molecules to conductive surfaces
10/06/2005US20050223418 Porcine CMP-N-Acetylneuraminic acid hydroxylase gene
10/06/2005US20050222627 Method and apparatus for treating bodily tissues with medicinal substance
10/06/2005US20050221492 Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer
10/06/2005US20050221467 Polypeptides which codes mutant phytoene desaturase gene; genetic engineered cells
10/06/2005US20050221465 for culturing a microorganism in a growth medium prepared from a sterile nutrient composition derived from the biomass of a culture of bacteria including methanotrophic bacteria; suitable for use as growth substrates for heterotrophic microorganisms
10/06/2005US20050221400 Monoclonal antibody comprising an antigen binding site that binds specifically to PSCA protein wherein monoclonal antibody comprises the amino acid sequence of the variable heavy chain region and the variable light chain region of antibody secreted by hybridoma assigned A.T.C.C. Accession No.: PTA-6697
10/06/2005US20050221383 Osteoarthritis biomarkers and uses thereof
10/06/2005US20050221316 Method for synthesising templated molecules
10/06/2005US20050220795 Complementarity determining regions which bind to catalytic domain of aspartyl (asparaginyl) beta -hydroxylase; diagnosis and treatment of cancer; readily penetrates tumors, no side effects, less toxic
10/06/2005CA2561302A1 Mutated xylose reductase in xylose-fermentation by s. cerevisiae
10/06/2005CA2560894A1 Traits in recombinant xylose-growing saccharomyces cerevisiae strains using genome-wide transcription analysis
10/05/2005EP1581661A2 Aflp-based method for integrating physical and genetic maps
10/05/2005EP1581654A2 Array oligomer synthesis and use
10/05/2005EP1581636A2 Methods using gene trapped stem cells for marking pathways of stem cell differentiation and making and isolating differentiated cells
10/05/2005EP1581618A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/04/2005US6951650 Antigenic class of avian reoviruses
09/2005
09/29/2005WO2005056752A3 Methods and compositions for delivering polynucleotides
09/29/2005WO2005054440A3 A biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
09/29/2005WO2005042697A3 Compounds, compositions and methods
09/29/2005WO2005038005A9 Shc proteins as therapeutic targets in proliferative diseases
09/29/2005WO2005014792A3 Preservation of biomaterials with transported preservation agents
09/29/2005WO2005014787A3 Genetic elements conferring flower petal-specific transgene expression
09/29/2005WO2005007820A3 Activated protein c variants with normal cytoprotective activity but reduced anticoagulant activity
09/29/2005WO2005003295A3 Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds
09/29/2005WO2004101737A3 A novel adjuvant capable of specifically activating the adaptive immune response
09/29/2005WO2004092338A3 Compositions, splice variants and methods relating to cancer specific genes and proteins
09/29/2005WO2004085618A3 Method of screening for target ligands
09/29/2005WO2004076632A3 Methods of screening for trpm5 modulators
09/29/2005WO2004070008A8 Methods and compositions for using suramin, pentosan polysulfate, telomerase antisense, and telomerase inhibitors
09/29/2005US20050216975 Nucleotide sequences coding oxidoreductase for use in transfer, expression and production of omega-3 and omega-6 fatty acids in yarrowia
09/29/2005US20050215634 Regulation of cell membrane-mediated effects
09/29/2005US20050214937 Surface proteins of leptospira
09/29/2005US20050214890 Novel "Cleave-N-Read" system for protease activity assay and methods of use thereof
09/29/2005US20050214809 Real-time detection of nucleic acids and proteins
09/29/2005US20050214796 Using cyclic amplification to generate probes for detection of preferential biopolymers; gene expression analysis
09/29/2005US20050214341 Three dimensional, malleable cell culture; tissue engineering; pluripotent cells
09/29/2005US20050214316 Generating and sequencing an infectious bursal disease virus cDNA from sample suspected of having a strain of IBDV, aligning the sequence with one or more IBDV sequences, and comparing relatedness of aligned IBDV sequences; selecting a vaccine for chickens, ducks, geese, pheasants, quail and turkeys.
09/29/2005US20050214306 Surface proteins of leptospira
09/29/2005US20050214262 Population of hematopoietic cells, made to exhibit a greater clonogenic potential, engraftment potential, immune system reconstitution potential and/or proportion of CD34+ positive cells by culturing with a transition metal compound that chelates copper such as tetraethylenepentamine
09/29/2005US20050214219 24p3 receptors and uses thereof
09/28/2005EP1580271A2 Human Orphan G Protein-Coupled Receptors
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 100